161 applications for medicines with conformity assessment are online, Zhengda Tianqing, Kelun, Qilu, Shiyao

Recently, Shandong Province issued a notice on the publicity of the results of drug audit in Shandong Province, involving 161 drugs, including Haoran, a pharmaceutical company including Zhengda Tianqing, Kelun, Qilu and Shiyao Relevant enterprises and medical institutions: according to the requirements of Shandong Medical Security Bureau's notice on online purchase of drugs through quality and efficacy consistency evaluation and new approval for listing (Lu medical insurance Fa [2019] No 20) and notice on online purchase of drugs through quality and efficacy consistency evaluation, the application materials of enterprises are reviewed in the form of qualification Now the audit results are publicized Publicity period: from April 22, 2019 to 17:00 on April 24, 2019 If there is any objection to the contents of the publicity, please submit the materials (with electronic seal) through "Shandong province centralized drug procurement platform" - "complaint management" within the publicity period The deadline is 17:00 on April 24, 2019, and the overdue materials will not be accepted The submitted materials shall be true and effective, and no malicious complaints shall be made If the application enterprise or product qualification fails to pass the review, there is no need to appeal, it can be supplemented through the original project of the platform, and the relevant materials to be reviewed are enough The undeclared enterprises and products can be declared through the project of "2019 (the second batch) drug online procurement through quality and efficacy consistency evaluation" Consultation Tel.: 0531-67873129 supervision Tel.: 0531-67873118 Shandong public resources trading center April 19, 2019